Trial Profile
Randomized, Double-Masked, Placebo-Controlled Multiple-Dose Phase 1 Study to Evaluate the Safety and Tolerability of Different Doses of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Polihexanide (Primary)
- Indications Acanthamoeba infections; Keratitis
- Focus Adverse reactions
- Sponsors SIFI
- 01 Feb 2021 Results published in the Media Release
- 19 Jul 2017 New trial record